Use of prostaglandin E1 for papaverine-failed erections.
The use of prostaglandin E1 is introduced as a pharmacologic agent that can produce artificial erections in patients who have failed the initial papaverine test or who were on self-injection programs and later lost rigidity.
Reiss
H
H
Department of Urology, New York University School of Medicine, New York.
D000328:Adult; D000368:Aged; D000527:Alprostadil / Q000627:therapeutic use*; D007172:Erectile Dysfunction / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000627:therapeutic use*; D010410:Penile Erection / Q000187:drug effects*; D010413:Penis / Q000033:anatomy & histology
D010208:Papaverine; D000527:Alprostadil